Documente Academic
Documente Profesional
Documente Cultură
Medicamento: Pregabalina
Mecanismo De Accin: .Algunos mecanismos posibles han sido sugeridos, al parecer se une a
la subunidad de alfa - 2 - delta de un canal dependiente de calcio que puede impedir la
entrada de calcio y atenuar la transmisin sinptica. Tambin ajusta el lanzamiento de
algunos neurotransmisores incluyendo glutamato, noradrenalina, y sustancia P . El resultado
principal de la accin de pregabalina parece ser la inhibicin de la excitabilidad neuronal
Prerequisitos: Haber agotado todas las posibilidades teraputicas del plan obligatorio de salud
para el tratamiento de la Epilepsia: Fenitoina, Carbamazepina, Acido valproico, Clonazepam,
a dosis mximas o haber presentado efectos adversos a las combinaciones posibles.
Los estudios fueron inadecuados para soportar una conclusin de que las drogas ms nuevas
en general mejoraban la calidad de vida (Recomendacin A NICE)
Bibliografia
1) Pharmacologic management of neuropathic pain: evidence-based recommendations
Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser
JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC,
Wallace MS. Pharmacologic management of neuropathic pain: evidence-based
recommendations. Pain 2007 Dec 5; 132(3):237-51.
2) Newer drugs for epilepsy in adults..National Institute for Clinical Excellence (NICE). Newer
drugs for epilepsy in adults. London (UK): National Institute for Clinical Excellence (NICE);
2004 Mar.
3) Pain (chronic).Work Loss Data Institute. Pain (chronic). Corpus Christi (TX): Work Loss Data
Institute; 2007 Jul 5
4) Epilepsy in adults. Singapore Ministry of Health. Epilepsy in adults. Singapore: Singapore
Ministry of Health; 2007 Jan.
5) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy:
report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards
Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil
C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ Jr;
Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE Jr; Sachdeo RC; Beydoun A; Glauser
TA. Neurology 2004 Apr 27;62(8):1261-73
6) 3-substituted GABA analogs with central nervous system activity: a review.Bryans JS;
Wustrow DJ Med Res Rev 1999 Mar;19(2):149-77.
7) Pregabalin (lyrica) for neuropathic pain and epilepsy. Med Lett Drugs Ther 2005 Sep
12;47(1217):75-6, 73
8) Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of
carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Brodie
MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson
GL; Bockbrader HN Epilepsia 2005 Sep;46(9):1407-13
Staff de Medicamentos No POS - Staff Nacional de Alto Costo
9) Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, doseresponse study in adults with partial seizures.Arroyo S; Anhut H; Kugler AR; Lee CM; Knapp
LE; Garofalo EA; Messmer S Epilepsia 2004 Jan;45(1):20-7.
10) Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA Neurology 2005 Feb
8;64(3):475-80.